Cargando…

Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities

[Image: see text] In this study, we report the design and synthesis of a series of novel thiophene-arylamide compounds derived from the noncovalent decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1) inhibitor TCA1 through a structure-based scaffold hopping strategy. Systematic optimization of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pengxu, Batt, Sarah M., Wang, Bin, Fu, Lei, Qin, Rongfei, Lu, Yu, Li, Gang, Besra, Gurdyal S., Huang, Haihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154581/ https://www.ncbi.nlm.nih.gov/pubmed/33852302 http://dx.doi.org/10.1021/acs.jmedchem.1c00263

Ejemplares similares

Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
por: Liu, Renhe, et al.
Publicado: (2017)

DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023)

Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis
por: Batt, Sarah M., et al.
Publicado: (2023)

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
por: Richter, Adrian, et al.
Publicado: (2018)

Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis
por: Xiang, Wang, et al.
Publicado: (2023)

Virtual Screening of Small Molecular Inhibitors against DprE1
por: Zhang, Gang, et al.
Publicado: (2018)

Identification of hydantoin based Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools
por: Mali, Suraj N., et al.
Publicado: (2022)

Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
por: Bhutani, Isha, et al.
Publicado: (2015)

OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
por: Hariguchi, Norimitsu, et al.
Publicado: (2020)

Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence
por: Chhabra, Sonali, et al.
Publicado: (2021)

Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1): challenging target for antitubercular drug discovery
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
por: Chikhale, Rupesh V, et al.
Publicado: (2014)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
por: Sarathy, Jickky Palmae, et al.
Publicado: (2022)

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties
por: Amado, Patrícia S. M., et al.
Publicado: (2022)

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
por: Piton, Jérémie, et al.
Publicado: (2018)

Synthesis and Structure–Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents
por: Yadav, Veena D., et al.
Publicado: (2023)

Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
por: Ramey, Michelle E., et al.
Publicado: (2023)

Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity
por: Shi, Xiao-Yi, et al.
Publicado: (2023)

Modular Synthesis of Diverse Natural Product‐Like Macrocycles: Discovery of Hits with Antimycobacterial Activity
por: Dow, Mark, et al.
Publicado: (2017)

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
por: Robertson, Gregory T., et al.
Publicado: (2021)

Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors
por: Gawad, Jineetkumar, et al.
Publicado: (2018)

Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets
por: Trofimov, Valentin, et al.
Publicado: (2018)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

Alphalinolenic acid, a potent inhibitor of fatty acid synthase antimycobacterial agent
por: Jainu, Mallika, et al.
Publicado: (2014)

Discovery of quinolone derivatives as antimycobacterial agents
por: Liu, Kun-Lin, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of Arylamide Sulphonate Derivatives as Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 and -3 Inhibitors
por: Ullah, Saif, et al.
Publicado: (2022)

The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system
por: Batt, Sarah M., et al.
Publicado: (2020)

DER NEWSLETTER DES DPR
Publicado: (2022)

Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis
por: Shelton, Catherine D., et al.
Publicado: (2021)

Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors
por: El-Gamal, Mohammed I., et al.
Publicado: (2016)

New flavone-based arylamides as potential V600E-BRAF inhibitors: Molecular docking, DFT, and pharmacokinetic properties
por: Umar, Abdullahi B., et al.
Publicado: (2023)

Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall
por: Batt, Sarah M., et al.
Publicado: (2020)

Novel N-arylamide derivatives of (S)-perillic acid ((S)-PA): in vitro and in vivo cytotoxicity and antitumor evaluation
por: Mukhtar, Yusif Mohammed, et al.
Publicado: (2019)

Synthesis of enantiomerically pure N-(2,3-dihydroxypropyl)arylamides via oxidative esterification
por: Raghunadh, Akula, et al.
Publicado: (2013)

Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile
por: Stefanowicz, Jacek, et al.
Publicado: (2018)

Atom-Economical Synthesis of N-Arylamides Utilizing Isopropenyl Esters with Heterogeneous Acid Catalysts
por: Ichitsuka, Tomohiro, et al.
Publicado: (2023)

Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line
por: Elrayess, Ranza, et al.
Publicado: (2020)

Resolution enhancement with deblurring by pixel reassignment (DPR)
por: Zhao, Bingying, et al.
Publicado: (2023)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03rjprvms5f08k7rh3ptri4glm